Giovanni Fruscio
Giovanni Fruscio has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Quarta
DLV System s.r.l., Research Section, Viale della Resistenza, 19, 87036 Quattromiglia, Italy
1 shared publication - Antonio Ballarin
University Canada West, Vancouver, BC, Canada
1 shared publication - Catherine Ballarin
Trillium Technology London, UK
1 shared publication - Danila De Vito
Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari Aldo Moro, 70124 Bari, Italy
1 shared publication - Gabriel Gustafsson Hall
Visby Hospital, Section of Clinical Microbiology and Infectious Diseases, Department of Medical Sciences, 62156 Visby, Sweden
1 shared publication - Germana Lo Sapio
University Canada West, Vancouver, BC, Canada
1 shared publication
Latest Publications
- 1 January 2024
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 3220 (1) , 020001
A reasonable methodology for the realization of ethical artificial intelligence artifacts: From turing test to ethics tests
Law is the reference system that regulates the methods of interaction within a community of individuals, and ethics describes the codes of conduct and morality Law is the reference system that regulates the methods of interaction within a community of individuals, and ethics describes the codes of conduct and morality
- 1 January 2024
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 3220 (1) , 020001
A reasonable methodology for the realization of ethical artificial intelligence artifacts: From turing test to ethics tests
Law is the reference system that regulates the methods of interaction within a community of individuals, and ethics describes the codes of conduct and morality Law is the reference system that regulates the methods of interaction within a community of individuals, and ethics describes the codes of conduct and morality
- Open Access
Antibiotic Abuse and Antimicrobial Resistance in Hospital Environment: A Retrospective Observational Comparative Study
Background and Objectives: Antimicrobial resistance represents a serious problem, and it may be life-threatening in the case of severe hospital-acquired infections (HAI). Antibiotic abuse and multidrug resistance (MDR) have significantly increased this burden in the last decades. The aim of this study was to investigate the distribution and susceptibility rates of five selected bacterial species (E. coli, K. pneumoniae, P. aeruginosa, S. aureus and E. faecium) in two healthcare settings located in the Apulia region (Italy). Materials and Methods: Setting n.1 was a university hospital and setting n.2 was a research institute working on oncological patients. All the enrolled patients were diagnosed for bacterial HAI. The observation period was between August and September 2021. Clinical samples were obtained from several biological sources, in different hospital wards. Bacterial identification and susceptibility were tested by using the software VITEC 2 Single system. Results: In this study, a higher incidence of multi-drug-resistant K. pneumoniae was reported (42,2% in setting n.1 and 50% in setting n.2), with respect to the Italian 2019 statistics report (30.3%). All the isolates of E. faecium and S. aureus were susceptible to linezolid. All the bacterial isolates of P. aeruginosa and most of K. pneumoniae were susceptible to ceftazidime–avibactam. Amikacin and nitrofurantoin represented a good option for treating E. coli infections. Multidrug-resistant (MDR) P. aeruginosa, methicillin-resistant S. aureus (MRSA) and vancomycin-resistantE. faecium (VRE) had a lower incidence in the clinical setting, with respect to E. coli and K. pneumoniae. Conclusions: The data obtained in this study can support clinicians towards a rational and safe use of antibiotics for treating the infections caused by these resistant strains, to enhance the overall efficacy of the current antibiotic protocols used in the main healthcare environments.
Open AccessAntibiotic Abuse and Antimicrobial Resistance in Hospital Environment: A Retrospective Observational Comparative Study
Background and Objectives: Antimicrobial resistance represents a serious problem, and it may be life-threatening in the case of severe hospital-acquired infections (HAI). Antibiotic abuse and multidrug resistance (MDR) have significantly increased this burden in the last decades. The aim of this study was to investigate the distribution and susceptibility rates of five selected bacterial species (E. coli, K. pneumoniae, P. aeruginosa, S. aureus and E. faecium) in two healthcare settings located in the Apulia region (Italy). Materials and Methods: Setting n.1 was a university hospital and setting n.2 was a research institute working on oncological patients. All the enrolled patients were diagnosed for bacterial HAI. The observation period was between August and September 2021. Clinical samples were obtained from several biological sources, in different hospital wards. Bacterial identification and susceptibility were tested by using the software VITEC 2 Single system. Results: In this study, a higher incidence of multi-drug-resistant K. pneumoniae was reported (42,2% in setting n.1 and 50% in setting n.2), with respect to the Italian 2019 statistics report (30.3%). All the isolates of E. faecium and S. aureus were susceptible to linezolid. All the bacterial isolates of P. aeruginosa and most of K. pneumoniae were susceptible to ceftazidime–avibactam. Amikacin and nitrofurantoin represented a good option for treating E. coli infections. Multidrug-resistant (MDR) P. aeruginosa, methicillin-resistant S. aureus (MRSA) and vancomycin-resistantE. faecium (VRE) had a lower incidence in the clinical setting, with respect to E. coli and K. pneumoniae. Conclusions: The data obtained in this study can support clinicians towards a rational and safe use of antibiotics for treating the infections caused by these resistant strains, to enhance the overall efficacy of the current antibiotic protocols used in the main healthcare environments.